Insider filing · ROIV
Daniel Allen Gold
Director
profile →
Roivant Sciences Ltd.
ROIV · Healthcare · 75 filings in 24 months
ticker →
Daniel Allen Gold sold $26.3M of Roivant Sciences (ROIV)
Executed Nov 19 2025, disclosed Nov 21 2025, 2 days later.
Value, as filed
$26.3M
1,300,000 sh across 4 lots
Executed
Nov 19 2025
the trade date, as filed
Disclosed
Nov 21 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
DGDaniel Allen Gold (Director) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $49.4M of ROIV (1,438,163 sh across 5 lots, as filed), executed Jun 26.
The name
ROIVHealthcare · Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicine…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Daniel Allen Gold in ROIV
ROIVSALE
Roivant Sciences Ltd.
$49.4M1,438,163 sh across 5 lots
Exec Jun 26
Filed Jun 30 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. $32.7M
1,225,784 sh across 5 lots
Exec Feb 11
Filed Feb 13 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. $39.1M
1,694,614 sh across 5 lots
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. $51.8M
4,426,000 sh across 6 lots
Exec Sep 24 2024
Filed Sep 26 2024 · 5:30 PM ET